In this GEN webinar, Halo Labs CSO and Co-founder Bernardo Cordovez, PhD, will help us understand the nature of sub-visible particles and if it is your drug product that is aggregating or some other potentially unsafe material.
In this GEN webinar, sponsored by SCIEX, we will take a closer look at the latest technologies purpose-built to meet the challenges of the biopharmaceutical industry. For instance, we will hear details about a multi-capillary electrophoresis system that enables researchers to run multiple samples significantly faster than traditional methods, allowing for high-throughput analysis of protein purity and stability, as well as genome integrity and AAV purity.
In the September edition of GEN Live, we’re joined by leaders in the field to discuss where cancer research is now, the challenges it faces as it moves forward, and to preview the innovative new ways that cancer is being targeted to develop future therapies.
In this GEN webinar, sponsored by SomaLogic, our distinguished speaker, Dr. David Lanfear, will explore a new large-scale protein array, SomaScan, using an established heart failure (HF) patient registry to understand how the plasma proteome could meaningfully predict the risk of death or HF worsening and add to best conventional risk stratification, including clinical score and natriuretic peptides.
In this GEN Keynote webinar, sponsored by 10x Genomics, our distinguished guest, Dr. Marina Sirota, associate professor at UCSF, will describe how her laboratory is leveraging the genetic data across phenotypes to elucidate the genetic architecture of disease with a particular interest in autoimmune disorders.
In this GEN webinar, our distinguished speaker Dr. Kathy Rowlen, CEO and co-founder of InDevR, will review critical quality attributes for mRNA vaccines, related CMC issues and explain how the VaxArray platform can streamline development and testing for multivalent drug products.
In this GEN webinar, sponsored by Corning, we will learn more about how patient-derived organoids are being put to use for personalized therapies for diseases such as pancreatic cancer. We will also hear about various screening applications using organoid-derived models.
From R&D through Process Development to Manufacturing, our CAR-T Connect virtual event offers a unique opportunity to interact with CAR-T therapy pioneers from start-ups to big pharma. This virtual event, sponsored by Sartorius, includes access to expert plenary presentations, lively Q&A and discussions, networking opportunities, and focused break-out sessions.
This GEN webinar, sponsored by Unchained Labs, will show that whether a nanoparticle’s payload is RNA, DNA, protein, or another API, Big Tuna handles buffer exchange and concentration while Stunner delivers dye-free, label-free, standard-free, hassle-free quant.